Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data

Go back to Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
(NASDAQ: BNTX) Delayed: 89.67 -1.62 (1.77%)
Previous Close $91.29    52 Week High $ 
Open $90.75    52 Week Low $ 
Day High $92.73    P/E N/A 
Day Low $89.03    EPS $ 
Volume 1,164,449       

Pfizer Inc. (NYSE: PFE) Delayed: 30.42 +0.57 (1.91%)
Previous Close $29.85    52 Week High $37.39 
Open $30.05    52 Week Low $28.25 
Day High $30.44    P/E 18.44 
Day Low $29.88    EPS $1.65 
Volume 28,697,226